Analysis by Product (Total Hip Replacement, Partial Hip Replacement, Revision Hip Replacement, and Hip Resurfacing), by Material (Metal-On-Metal, Metal-On-Polyethylene, Ceramic-On-Polyethylene, Ceramic-On-Metal, and Ceramic-On-Ceramic); by End User (Hospitals, Orthopedic Clinics, and Ambulatory Surgery Centers) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Buy Now
The global hip replacement market is estimated to garner a revenue of ~ USD 10 Billion by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~ USD 7 Billion in the year 2022. The growth can be attributed to rising prevalence of osteoarthritis in the population owing to any kind of accident, mishap or injury. Despite the existence of more than 100 different kinds of arthritis, osteoarthritis (OA), which affects approximate 30 million US adults, is the most widespread variety.
Get more information on this report:Download Sample PDF
Also there has been growing incidence of hip injuries owing to the number of accidents taking place including road accidents and sport injuries. As a result, the hip replacement surgeries is expected to considerably grow in the forecast period. Approximate, 1200 road crashes take place every day in India. Also the Journal of the American Academy of Orthopaedic Surgeons reports that athletic hip injuries make up around 6% of all sports injuries and are becoming more common.
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~6% |
|
Base Year Market Size (2022) |
~ USD 7 Billion |
|
Forecast Year Market Size (2033) |
~ USD 10 Billion |
|
Regional Scope |
|
Growth Drivers
Growing Geriatric Population - With ageing, the body might alter, which can also affect the health. One part of the body where changes can occur over time and cause chronic pain and even disability is the hips. Hence owing to this factor the hip replacement market is expected to grow over the forecast period. According to the National Institutes of Health, Over the next three decades, the number of Americans aged 65 and older is expected to nearly double, rising from 48 million to 88 million by 2050.
Growth in Spending over Healthcare - The study demonstrated by World Health Organization shows that between 2000 and 2018, global health spending increased steadily, reaching USD 8.3 trillion, or 10% of global GDP.
Growing Prevalence of Rheumatoid Arthritis - The most prevalent type of autoimmune arthritis is RA. More than 1 million Americans are impacted by it.
Increase in Number of Hip Fracture - Each year, approximately 76,000 hip fractures occur in the United Kingdom.
Rise in Number of Individuals Suffering from Degenerative Diseases - According to the World Health Organization, almost 10 million new cases of dementia are diagnosed each year, and there are already over 55 million people living with the condition worldwide.
Challenges
Side Effects of Replacement Surgeries - Owing to the device defects people are expected to suffer various side effects including allergic reactions, metal poisoning, infection, bone lose, and more. Hence owing to this factor the market is expected to be retrained during the forecast period.
High Price of the Procedure
Stringent Government Regulation
The global hip replacement market is segmented and analyzed for demand and supply by end user into hospitals, orthopedic clinics, and ambulatory surgery centers. Out of which, the orthopedic clinics segment is estimated to garner the largest revenue by the end of 2033, backed by increasing orthopedic surgeons, rising number of hospitals, people suffering from leg problems and other factors. According to the National Library of Medicine, the number of distinct orthopedic surgeons increased from 21,216 in 2012 to 21,553 in 2020, a 1.6% rise, over those years.
The North America hip replacement market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033, owing to rising number of hip arthroplasty, high expenditure on health expenditure, growth in healthcare sector, increasing disposable income and other factors. A total of almost 2.4 million hip and knee surgeries—representing an 18.3% increase in total procedural volume compared to that in 2020—were reported in the yearly report from more than 1150 facilities. This equates to a 40% capture rate of the entire annual volume of total joint arthroplasty (TJA) performed in the United States.
Our in-depth analysis of the global hip replacement market includes the following segments:
|
By Product |
|
|
By Material |
|
|
By End - User |
|
Zimmer Biomet
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Ans: The major factors driving the growth of the market are growing geriatric population, growth in spending over healthcare, growing prevalence of rheumatoid arthritis, and others.
Ans: The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 – 2033.
Ans: Side effects of replacement surgeries, high price of the procedures, and stringent government regulation are some of the major factors expected to hinder the growth of the market.
Ans: The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
Ans: The major players in the market are Zimmer Biomet, Johnson & Johnson Private Limited, Stryker Corporation, Smith & Nephew, and more.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by product, material, end user, and by region.
Ans: The orthopaedic clinics segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
